輪胎板塊走強 開啟新一輪漲價潮
格隆匯12月31日丨輪胎板塊走強,賽輪輪胎、玲瓏輪胎漲停,三角輪胎漲近5%,風神股份、豪邁科技、貴州輪胎等紛紛跟漲。據業內消息,近期,多家輪胎企業把漲價通知單已經排到了2021年。山東金宇橡膠決定自2021年起對產品價格進行調整,本次上調幅度為2%~3%。朝陽華興萬達輪胎髮布價格調整通知函,對公司內胎在原價格基礎上調3個點,墊帶在原價格基礎上調5個點。山東皓宇橡膠發佈漲價通知,對生產的TBR產品全系列價格進行2%上浮調整。除國產輪胎大廠外,韓泰、佳通、固特異、普利司通等外資輪胎企業也開始漲價,各家累計漲價幅度在5%以上。業內人士分析,短期內供需矛盾難以緩解,同9月份相比,預期明年1月份漲價幅度可能在6%~11%之間。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.